Drug Shortage Report for CIPROFLOXACIN INTRAVENOUS INFUSION, BP

Last updated on 2017-10-05 History
Report ID 19335
Drug Identification Number 02304546
Brand name CIPROFLOXACIN INTRAVENOUS INFUSION, BP
Common or Proper name CIPROFLOX
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100/200 ML
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-08-14 French Compare
v1 2017-08-14 English Compare